INVESTMENT CASE
High impact science
We invest in companies addressing significant unmet needs in healthcare, which have the potential to deliver breakthrough treatments to patients.
Read more about our investment strategy here
Expertise
We provide more than just capital when we invest. We typically take a board seat and a hands-on approach to support our companies growth. We provide scientific and commercial experience to help navigate clinical and operational hurdles.
Access to a sustainable model
Capital realised from investments is recycled onto the balance sheet to invest in new life science opportunities.
Strong pipeline
We have access to a strong pipeline of opportunities through our global networks and reach. Our portfolio companies are collectively running multiple clinical trials, which provides significant opportunity for growth.